Cargando…

Pancancer network analysis reveals key master regulators for cancer invasiveness

BACKGROUND: Tumor invasiveness reflects numerous biological changes, including tumorigenesis, progression, and metastasis. To decipher the role of transcriptional regulators (TR) involved in tumor invasiveness, we performed a systematic network-based pan-cancer assessment of master regulators of can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jethalia, Mahesh, Jani, Siddhi P., Ceccarelli, Michele, Mall, Raghvendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440887/ https://www.ncbi.nlm.nih.gov/pubmed/37599366 http://dx.doi.org/10.1186/s12967-023-04435-6

Ejemplares similares

Network-based identification of key master regulators associated with an immune-silent cancer phenotype
por: Mall, Raghvendra, et al.
Publicado: (2021)

Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
por: Mall, Raghvendra, et al.
Publicado: (2022)

Detection of statistically significant network changes in complex biological networks
por: Mall, Raghvendra, et al.
Publicado: (2017)

Pancancer survival analysis of cancer hallmark genes
por: Nagy, Ádám, et al.
Publicado: (2021)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell
por: Liu, Ranran, et al.
Publicado: (2023)

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
por: Wu, Changwu, et al.
Publicado: (2021)

Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors
por: Lin, Xin, et al.
Publicado: (2022)

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
por: Song, Chengyang, et al.
Publicado: (2023)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2
por: Bousquets-Muñoz, Pablo, et al.
Publicado: (2022)

Deep learning with multimodal representation for pancancer prognosis prediction
por: Cheerla, Anika, et al.
Publicado: (2019)

CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023)

Pancancer analysis of DNA methylation-driven genes using MethylMix
por: Gevaert, Olivier, et al.
Publicado: (2015)

The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis
por: Liu, Kui, et al.
Publicado: (2021)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

A pancancer analysis of the oncogenic role of ZNRF2 in human tumours
por: Shi, Fujie, et al.
Publicado: (2023)

A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy
por: He, Shengfu, et al.
Publicado: (2022)

In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis
por: Wu, Zixuan, et al.
Publicado: (2022)

Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes
por: Yu, Lishan, et al.
Publicado: (2022)

Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4
por: Yang, Ziyue, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis
por: Yang, Jing, et al.
Publicado: (2022)

In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
por: Krupar, Rosemarie, et al.
Publicado: (2020)

Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes
por: Lu, Yuxing, et al.
Publicado: (2023)

Learning Individual Survival Models from PanCancer Whole Transcriptome Data
por: Kumar, Neeraj, et al.
Publicado: (2023)

An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer
por: Zhou, Yiyi, et al.
Publicado: (2022)

Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
por: Remo, Andrea, et al.
Publicado: (2015)

Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response
por: Champion, Magali, et al.
Publicado: (2017)

Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival
por: Liu, Qiaojun, et al.
Publicado: (2022)

Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance
por: Chen, Weiwei, et al.
Publicado: (2023)

A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors
por: Dai, Peng, et al.
Publicado: (2023)

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs
por: Osmanbeyoglu, Hatice U., et al.
Publicado: (2017)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
por: Zhou, Lingyi, et al.
Publicado: (2022)

Does the LHPP gene share a common biological function in pancancer progression?
por: Guo, Kai, et al.
Publicado: (2022)

Pilot Nanostring PanCancer pathway analysis of colon adenocarcinoma in a tertiary healthcare centre in Kerala, India
por: Ariyannur, Prasanth S, et al.
Publicado: (2021)

A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers
por: Li, Juanni, et al.
Publicado: (2021)

Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis
por: Li, Sicong, et al.
Publicado: (2022)

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020)

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
por: Deng, Chao, et al.
Publicado: (2021)

A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors
por: Wu, Yunhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nn69l6i935hn1dvmnkf7l39acl